insights_auto
Outlook: 32.0% bullish·12.0% bearish
Go to analysischevron_right
ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$43.49
arrow_upward
+0.88%(+0.38) 1D
Nov 19, 12:27:44 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 12 analysts giving stock ratings to ARWR in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ARWR in the last 3 months.
Highest
Current $43.49
$126.00 (+189.72%)
Average
$106.56 (+145.02%)
Lowest
$74.00 (+70.15%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Eric Joseph Citi | Buy | Maintained | $105.00 | +141.4% | 11/17/2026 |
Jason Gerberry Bank of America Securities | Buy | Maintained | - | - | 11/13/2026 |
Luca Issi RBC Capital | Buy | Reiterated | $100.00 | +129.9% | 11/13/2026 |
Michael Ulz Morgan Stanley | Buy | Maintained | $106.00 | +143.7% | 11/13/2026 |
Unknown Analyst UBS | Buy | Reiterated | $109.00 | +150.6% | 11/13/2026 |
James Condulis Stifel Nicolaus | Buy | Maintained | $96.00 | +120.7% | 11/13/2026 |
Edward Tenthoff Piper Sandler | Buy | Reiterated | $126.00 | +189.7% | 11/13/2026 |
Patrick Trucchio H.C. Wainwright | Buy | Reiterated | $120.00 | +175.9% | 11/11/2026 |
Madison Elsaadi B. Riley Securities | Buy | Maintained | $123.00 | +182.8% | 11/10/2026 |
Brian Cheng J.P. Morgan | Buy | Reiterated | - | - | 10/15/2026 |
Joon Lee UBS | Buy | Reiterated | $109.00 | +150.6% | 10/15/2026 |
Andrea Newkirk Goldman Sachs | Hold | Initiated | $74.00 | +70.2% | 09/24/2026 |
Joseph Thome TD Cowen | Buy | Maintained | - | - | 08/30/2026 |
Keay Nakae Chardan Capital | Buy | Maintained | $115.00 | +164.4% | 08/04/2026 |
William Pickering Bernstein | Hold | Reiterated | $46.00 | +5.8% | 05/13/2026 |
Mani Foroohar Leerink Partners | Hold | Maintained | - | - | 03/26/2026 |